Roche Reports Positive Phase III Results for Feneb...
Category : Clinical Trial Update 11 November 2025Roche announced that its investigational Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Roche announced that its investigational Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib...
Gilead Sciences has presented new long-term and real-world data supporting the safety and efficacy o...
Cordis announced positive results from two pivotal randomized clinical trials — SELUTION DeNov...
Takeda has announced new interim data from its Phase 1b, open-label, proof-of-concept study of mezag...
Sanofi and Regeneron have announced positive topline results from the pivotal Phase 3 LIBERTY-AFRS-A...